A short course of prednisone (under 14 days) does temporarily suppress parts of your immune system, but the effect is mild enough that most people face no meaningful increase in infection risk. Clinical trials comparing short-term steroid users to non-users found virtually identical infection rates: 5.8% versus 5.4%, with no statistically significant difference between the two groups. So while prednisone is technically an immunosuppressant at any dose, a brief course is unlikely to leave you vulnerable in a way that changes your daily life.
How Prednisone Affects Your Immune System
Prednisone works by entering your cells and altering how certain genes behave. Specifically, it blocks the production of signaling molecules called cytokines that your immune system uses to coordinate its response to threats. It also reduces the number of circulating lymphocytes, the white blood cells responsible for identifying and attacking infections and abnormal cells. At the same time, it slows down the movement of other immune cells to sites of inflammation, which is exactly why it’s so effective at reducing swelling, pain, and allergic reactions.
These changes happen quickly. Within hours of taking a dose, your blood work will show a characteristic shift: a rise in one type of white blood cell (neutrophils), a drop in lymphocytes, and a decrease in certain other immune cells. This pattern can make your total white blood cell count look artificially high on a blood test, which can be confusing if you or your doctor aren’t expecting it. It doesn’t mean you’re fighting an infection. It’s a direct, predictable effect of the medication.
What Counts as “Short Term”
In medical research, a short course of oral corticosteroids is generally defined as less than 30 days. But the threshold that matters most for immune suppression is 14 days. The CDC and most clinicians use a specific cutoff: taking 20 mg or more of prednisone per day (or 2 mg per kilogram of body weight) for 14 consecutive days or longer is considered “high-dose” therapy, the point where immunosuppression becomes clinically significant.
Below that line, the immune effects are real but minor. A typical 5- to 7-day burst for an asthma flare, allergic reaction, or back pain falls well within the range that most doctors consider low-risk. Even a 10-day taper at moderate doses doesn’t cross the threshold that triggers concern about serious immune compromise.
Actual Infection Risk on a Short Course
The reassuring finding from randomized controlled trials is that short-term, lower-dose steroid courses show little to no increased risk of infection. One large analysis found the relative risk of infection for steroid-treated patients compared to untreated patients was 0.97, meaning essentially no difference at all.
The picture changes with longer use. Observational studies in people taking even low doses (around 5 mg per day) for years show a gradual increase in risk. People on 5 mg daily for three years had roughly double the odds of a serious bacterial infection compared to non-users. Those taking more than 10 mg daily long-term had a 2.3 times higher risk of being hospitalized for pneumonia. The pattern is clear: duration and cumulative exposure matter far more than a single short burst.
This doesn’t mean you should ignore basic precautions during your course. Washing your hands, avoiding obviously sick contacts, and keeping any wounds clean are all reasonable. But you don’t need to isolate yourself or treat a 6-day prednisone taper like chemotherapy.
Vaccines and Short-Term Prednisone
One practical question that comes up often is whether you need to reschedule a vaccination. The CDC’s guidelines are straightforward here. If your course is under 14 days, or your dose is below 20 mg per day, live-virus vaccines (like the MMR or shingles vaccine) are not contraindicated. You can receive them during or immediately after your course without needing to wait.
The waiting period only kicks in for high-dose therapy lasting 14 days or longer. In that case, the recommendation is to defer live-virus vaccines for at least one month after stopping. Inactivated vaccines (like the flu shot or tetanus booster) are considered safe regardless of dose or duration, though the immune response you build may be slightly blunted while you’re on the medication.
How Quickly Your Immune System Recovers
Prednisone has a biological half-life of about 18 to 36 hours, meaning its active effects in your body fade relatively quickly after your last dose. For a short course, most of the immune changes reverse within a few days to a week. Lymphocyte counts rebound, cytokine signaling normalizes, and your immune surveillance returns to its baseline pattern.
This is very different from long-term use, where the body’s own cortisol production can become suppressed (because your adrenal glands slow down when external steroids are present). A 5- to 10-day course rarely causes meaningful adrenal suppression, which is why many short courses can be stopped abruptly or with a brief taper rather than a long, gradual reduction.
If you’ve been prescribed a short burst and you’re worried about getting sick during or right after, the window of slightly reduced immune function is narrow. Within a week of your last pill, your immune system is functioning normally again for all practical purposes.
When the Risk Is Higher
Certain situations can amplify even the mild immunosuppressive effects of a short course. If you’re already immunocompromised from another condition or medication, elderly, or managing a chronic illness like diabetes, the baseline risk of infection is higher to begin with, and prednisone adds to that. People with diabetes should also know that prednisone reliably raises blood sugar, sometimes dramatically, which can indirectly worsen infection risk by creating a more favorable environment for bacteria and fungi.
Repeated short courses also deserve attention. If you find yourself on prednisone bursts several times a year for recurring asthma or autoimmune flares, the cumulative exposure starts to resemble long-term use even though each individual course is brief. The infection risk data for “short-term” users assumes occasional use, not frequent cycling.